Anti-breast cancer-induced cardiomyopathy: Mechanisms and future directions
Authors:
- Chunping LiuCLChunping Liu
Open Access
- 28 August 2023
- journal article
- review article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 166, 115373
Abstract
No abstract availableKeywords
Funding Information
- Guangzhou Municipal Science and Technology Project (202102010287)
- Special Fund Project for Science and Technology Innovation Strategy of Guangdong Province
- Basic and Applied Basic Research Foundation of Guangdong Province (2021A1515012573)
- Basic and Applied Basic Research Foundation of Guangdong Province (2022A1515010395)
- National Natural Science Foundation of China (81803919)
- National Natural Science Foundation of China (82104495)
- National Natural Science Foundation of China (82174161)
This publication has 110 references indexed in Scilit:
- Identification of the molecular basis of doxorubicin-induced cardiotoxicityNature Medicine, 2012
- Assessment of Echocardiography and Biomarkers for the Extended Prediction of Cardiotoxicity in Patients Treated With Anthracyclines, Taxanes, and TrastuzumabCirculation: Cardiovascular Imaging, 2012
- Mitochondria Death/Survival Signaling Pathways in Cardiotoxicity Induced by Anthracyclines and Anticancer-Targeted TherapiesBiochemistry Research International, 2012
- Platinum-Based Compounds and Risk for Cardiovascular Toxicity in the Elderly: Role of the Antioxidants in ChemopreventionRejuvenation Research, 2011
- Role of Three-Dimensional Echocardiography in Breast Cancer: Comparison With Two-Dimensional Echocardiography, Multiple-Gated Acquisition Scans, and Cardiac Magnetic Resonance ImagingJournal of Clinical Oncology, 2010
- Transcription Inhibition by Platinum−DNA Cross-Links in Live Mammalian CellsJournal of the American Chemical Society, 2010
- Anthracycline Cardiomyopathy Is Mediated by Depletion of the Cardiac Stem Cell Pool and Is Rescued by Restoration of Progenitor Cell FunctionCirculation, 2010
- Pravastatin attenuates carboplatin-induced cardiotoxicity via inhibition of oxidative stress associated apoptosisApoptosis, 2008
- The Bcr-Abl tyrosine kinase inhibitor imatinib and promising new agents against Philadelphia chromosome-positive leukemiasInternational Journal of Clinical Oncology, 2007
- The frequency and pattern of cardiotoxicity observed with capecitabine used in conjunction with oxaliplatin in patients treated for advanced colorectal cancer (CRC)European Journal of Cancer, 2005